The Flow Cytometry Core has been established during the past year at the Columbia Diabetes Research Center. In the past funding cycle, there has been substantial growth in requests for flow cytometry services to assist diabetes investigators. The interest has been catalyzed by several initiatives to study pathogenesis and treatment of Type 1 Diabetes, including the new NIDDK-funded Epigenetics Program, the creation ofthe Columbia Center for Translational Immunology, and Genetics of autoimmunity initiative. In addition, the ability to isolate genetically modified rare cell populations from organs like brain, endocrine pancreas, adipose tissue, and gut has become critical to the research of DRC faculty. The DRC Flow Core was established in 2011 with substantial institutional as well as NIH support in the form of a Shared Instrumentation Grant. It was fully integrated within the DRC during the past year to meet the growing need ofthe DRC User base for flow cytometry, as demonstrated by 17 users supported by 33 grants, who have already obtained 5 new grants. The Core has already supported 16 publications as primary Core. User projections demonstrate a growing demand for these services, with 37 declared users for the coming year. The expertly staffed Flow Core is situated in renovated Department of Medicine space and houses four, state-of-the-art BD flow cytometers, including a 6-laser LSR II and a 4-laser BD Influx sorter. There is strong demand for these high-quality services. In particular, the BD Influx is only the second biosafety level-2 sorter available campus-wide for human cell sorting. More than 90% ofthe current use is by DRC faculty, a substantial portion of which are new NIH-funded Investigators recruited to CUMC in the previous funded period (Sykes, Farber, Yang). The Core Director Dr. Clynes is thoroughly integrated within the DRC and the Columbia biomedical community, and its Technical Director Dr. Siu Hong Ho is a superb operator and immunologist, enabling this Core to be a vibrant collaborative center of excellence.

Public Health Relevance

The identification and isolation of high quality, living cellular populations that occur at low frequency in different organ and tissue types is critical to the research endeavors ofthe Columbia diabetes community. The availability of this shared Core Facilities enables individual investigators to have access to expensive equipment and technically demanding methods that would not otherwise be affordable.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
New York
United States
Zip Code
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :
Tamucci, Kirstin A; Namwanje, Maria; Fan, Lihong et al. (2018) The dark side of browning. Protein Cell 9:152-163
Accili, Domenico (2018) Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes 67:1701-1709
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35
Laferrère, Blandine; Pattou, François (2018) Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 9:530
Shah, Ankit; Levesque, Kiarra; Pierini, Esmeralda et al. (2018) Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery. Diabetes Obes Metab 20:1018-1023
Haeusler, Rebecca A; McGraw, Timothy E; Accili, Domenico (2018) Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol 19:31-44

Showing the most recent 10 out of 225 publications